The Journal of Allergy and Clinical Immunology
Volume 116, Issue 1 , Pages 73-79 , July 2005

IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: Effect of immunotherapy

  • Kayhan T. Nouri-Aria, PhD, FRCPath

      Affiliations

    • These authors contributed equally to the present study.
    • ,
  • Charles Pilette, MD, PhD

      Affiliations

    • These authors contributed equally to the present study.
    • ,
  • Mikila R. Jacobson, PhD
    • ,
  • Hiroshi Watanabe, MD
    • ,
  • Stephen R. Durham, MD, FRCP

      Affiliations

    • Corresponding Author InformationReprint request: Stephen R. Durham, MD, FRCP, Upper Respiratory Medicine, Imperial College London, National Heart and Lung Institute, Dovehouse St, London SW3 6LY, United Kingdom.

Received 3 December 2004 ,Revised 4 March 2005 ,Accepted 9 March 2005.

References 

  1. Boyce JA. Mast cells: beyond IgE. J Allergy Clin Immunol. 2003;111:24–32
  2. Bochner BS, Schleimer RP. Mast cells, basophils and eosinophils: distinct but overlapping pathways for recruitment. Immunol Rev. 2001;179:5–15
  3. KleinJan A, McEuen AR, Dijkstra MD, Buckley MG, Walls AF, Fokkens WJ. Basophil and eosinophil accumulation and mast cell degranulation in the nasal mucosa of patients with hay fever after local allergen provocation. J Allergy Clin Immunol. 2000;106:677–686
  4. Macfarlane AJ, Kon OM, Smith SJ, Zeibecoglou K, Khan LN, Barata LT, et al. Basophils, eosinophils, and mast cells in atopic and nonatopic asthma and in late-phase allergic reactions in the lung and skin. J Allergy Clin Immunol. 2000;105:99–107
  5. Gauvreau GM, Lee JM, Watson RM, Irani AM, Schwartz LB, O'Byrne PM. Increased numbers of both airway basophils and mast cells in sputum after allergen inhalation challenge of atopic asthmatics. Am J Respir Crit Care Med. 2000;161:1473–1478
  6. Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol. 1998;102:558–562
  7. Wilson DR, Nouri-Aria KT, Walker SM, Pajno GB, O'Brien F, Jacobson MR, et al. Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season. J Allergy Clin Immunol. 2001;107:971–976
  8. Wilson DR, Irani AM, Walker SM, Jacobson MR, Mackay IS, Schwartz LB, et al. Grass pollen immunotherapy inhibits seasonal increases in basophils and eosinophils in the nasal epithelium. Clin Exp Allergy. 2001;31:1705–1713
  9. Hultner L, Druez C, Moeller J, Uyttenhove C, Schmitt E, Rude E, et al. Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9). Eur J Immunol. 1990;20:1413–1416
  10. Godfraind C, Louahed J, Faulkner H, Vink A, Warnier G, Grencis R, et al. Intraepithelial infiltration by mast cells with both connective tissue-type and mucosal-type characteristics in gut, trachea, and kidneys of IL-9 transgenic mice. J Immunol. 1998;160:3989–3996
  11. Druez C, Coulie P, Uyttenhove C, Van Snick J. Functional and biochemical characterization of mouse P40/IL-9 receptors. J Immunol. 1990;145:2494–2499
  12. Temann UA, Ray P, Flavell RA. Pulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology. J Clin Invest. 2002;109:29–39
  13. Hauber H-P, Bergeron C, Hamid Q. IL-9 in allergic inflammation. Int Arch Allergy Immunol. 2004;134:79–87
  14. McLane MP, Haczku A, van de Rijn M, Weiss C, Ferrante V, MacDonald D, et al. Interleukin-9 promotes allergen-induced eosinophilic inflammation and airway hyperresponsiveness in transgenic mice. Am J Respir Cell Mol Biol. 1998;19:713–720
  15. Dugas B, Renauld JC, Pene J, Bonnefoy JY, Peti-Frere C, Braquet P, et al. Interleukin-9 potentiates the interleukin-4-induced immunoglobulin (IgG, IgM and IgE) production by normal human B lymphocytes. Eur J Immunol. 1993;23:1687–1692
  16. Louahed J, Toda M, Jen J, Hamid Q, Renauld JC, Levitt RC, et al. Interleukin-9 upregulates mucus expression in the airways. Am J Respir Cell Mol Biol. 2000;22:649–656
  17. Soussi-Gounni A, Kontolemos M, Hamid Q. Role of IL-9 in the pathophysiology of allergic diseases. J Allergy Clin Immunol. 2001;107:575–582
  18. Nicolaides NC, Holroyd KJ, Ewart SL, Eleff SM, Kiser MB, Dragwa CR, et al. Interleukin 9: a candidate gene for asthma. Proc Natl Acad Sci U S A. 1997;94:13175–13180
  19. Shimbara A, Christodoulopoulos P, Soussi-Gounni A, Olivenstein R, Nakamura Y, Levitt RC, et al. IL-9 and its receptor in allergic and nonallergic lung disease: increased expression in asthma. J Allergy Clin Immunol. 2000;105:108–115
  20. Ying S, Meng Q, Kay AB, Robinson DS. Elevated expression of interleukin-9 mRNA in the bronchial mucosa of atopic asthmatics and allergen-induced cutaneous late-phase reaction: relationships to eosinophils, mast cells and T lymphocytes. Clin Exp Allergy. 2002;32:866–871
  21. Erpenbeck VJ, Hohlfeld JM, Volkmann B, Hagenberg A, Geldmacher H, Braun A, et al. Segmental allergen challenge in patients with atopic asthma leads to increased IL-9 expression in bronchoalveolar lavage fluid lymphocytes. J Allergy Clin Immunol. 2003;111:1319–1327
  22. Walker SM, Pajno GB, Lima MT, Wilson DR, Durham SR. Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial. J Allergy Clin Immunol. 2001;107:87–93
  23. Nilsen EM, Johanson F-E, Jahnsen FL, Lundin KEA, Scholz T, et al. Cytokine profiles of cultured microvascular endothelial cells from the human intestin. Gut. 1998;42:635–642
  24. Matsuzawa S, Sakashita K, Kinoshita T, Ito S, Yamashita T, Koike K. IL-9 enhances the growth of human mast cell progenitors under stimulation with stem cell factor. J Immunol. 2003;170:3461–3467
  25. Dus D, Krawczenko A, Zalecki P, Paprocka M, Wiedlocha A, Goupille C, et al. IL-7 receptor is present on human microvascular endothelial cells. Immunol Lett. 2003;68:163–168
  26. Borres MP, Irander K, Bjorksten B. Metachromatic cells in nasal mucosa after allergen challenge. Allergy. 1990;45:98–103
  27. Viegas M, Gomez E, Brooks J, Davies RJ. Changes in nasal mast cell numbers in and out of the pollen season. Int Arch Allergy Appl Immunol. 1987;82:275–276
  28. Durham SR, Ying S, Varney VA, Jacobson MR, Sudderick RM, Mackay IS, et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol. 1992;148:2390–2394
  29. Stassen M, Muller C, Arnold M, Hultner L, Klein-Hessling S, Neudorfl C, et al. IL-9 and IL-13 production by activated mast cells is strongly enhanced in the presence of lipopolysaccharide: NF-kappa B is decisively involved in the expression of IL-9. J Immunol. 2001;166:4391–4398
  30. Durham SR, Walker SM, Varga EM, Jacobson MR, O'Brien F, Noble W, et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med. 1999;341:468–475
  31. Otsuka H, Mezawa A, Ohnishi M, Okubo K, Seki H, Okuda M. Changes in nasal metachromatic cells during allergen immunotherapy. Clin Exp Allergy. 1991;21:115–119
  32. Ikeda RK, Miller M, Nayar J, Walker L, Cho JY, McElwain K, et al. Accumulation of peribronchial mast cells in a mouse model of ovalbumin allergen induced chronic airway inflammation: modulation by immunostimulatory DNA sequences. J Immunol. 2003;171:4860–4867
  33. Louahed J, Zhou Y, Maloy WL, Rani PU, Weiss C, Tomer Y, et al. Interleukin 9 promotes influx and local maturation of eosinophils. Blood. 2001;97:1035–1042
  34. McMillan SJ, Bishop B, Townsend MJ, McKenzie AN, Lloyd CM. The absence of interleukin 9 does not affect the development of allergen-induced pulmonary inflammation nor airway hyperreactivity. J Exp Med. 2002;195:51–57
  35. Cheng G, Arima M, Honda K, Hirata H, Eda F, Yoshida N, et al. Anti-interleukin-9 antibody treatment inhibits airway inflammation and hyperreactivity in mouse asthma model. Am J Respir Crit Care Med. 2002;166:409–416
  36. Levitt RC, McLane MP, MacDonald D, Ferrante V, Weiss C, Zhou T, et al. IL-9 pathway in asthma: new therapeutic targets for allergic inflammatory disorders. J Allergy Clin Immunol. 1999;103(suppl):S485–S491
  37. Renauld JC, Kermouni A, Vink A, Louahed J, Van Snick J. Interleukin-9 and its receptor: involvement in mast cell differentiation and T cell oncogenesis. J Leukoc Biol. 1995;57:353–360

 CP was supported by a research fellowship from the European Respiratory Society (Grant LTRF2002-037). This work was supported by the National Asthma Campaign (UK), Medical Research Council (UK), and ALK Abello (Horsholm, Denmark).Disclosure of potential conflict of interest: C. Pilette is supported by a European Respiratory Society (ERS) fellowship. S. Durham has consultant arrangements with and has received grants–research support from ALK-Abello and is on the speakers' bureau for ALK-Abello, GalxoSmithKline, Aventis, and UCB. All other authors—none disclosed.

PII: S0091-6749(05)00541-5

doi: 10.1016/j.jaci.2005.03.011

The Journal of Allergy and Clinical Immunology
Volume 116, Issue 1 , Pages 73-79 , July 2005

Article Tools

* Image Usage & Resolution